These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 6045130)

  • 1. Treatment of ulcerative colitis with antimetabolite 6-mercaptopurine.
    Lal HB; Caroli RK; Sengupta D; Malik RN; Basumalik SN; Khan MA
    J Assoc Physicians India; 1967 Mar; 15(3):129-36. PubMed ID: 6045130
    [No Abstract]   [Full Text] [Related]  

  • 2. [Azathioprine and 6-mercaptopurine for maintenance treatment in ulcerative colitis. A survey of a Cochrane review].
    Bjerrum JT; Nielsen OH
    Ugeskr Laeger; 2007 Dec; 169(50):4341-4. PubMed ID: 18211790
    [No Abstract]   [Full Text] [Related]  

  • 3. Efficacy and safety of thiopurinic immunomodulators (azathioprine and mercaptopurine) in steroid-dependent ulcerative colitis.
    Lopez-Sanroman A; Bermejo F; Carrera E; Garcia-Plaza A
    Aliment Pharmacol Ther; 2004 Jul; 20(2):161-6. PubMed ID: 15233695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The treatment of ulcerative colitis with "immunosuppressive" drugs.
    Korelitz BI
    Am J Gastroenterol; 1981 Sep; 76(3):297-8. PubMed ID: 7198378
    [No Abstract]   [Full Text] [Related]  

  • 5. The long-term outcome of ulcerative colitis treated with 6-mercaptopurine.
    George J; Present DH; Pou R; Bodian C; Rubin PH
    Am J Gastroenterol; 1996 Sep; 91(9):1711-4. PubMed ID: 8792685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A search for the optimal duration of treatment with 6-mercaptopurine for ulcerative colitis.
    Lobel EZ; Korelitz BI; Xuereb MA; Panagopoulos G
    Am J Gastroenterol; 2004 Mar; 99(3):462-5. PubMed ID: 15056086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunosuppressive agents in the treatment of Crohn's disease and ulcerative colitis.
    Hibi T; Iwao Y; Yajima T; Inoue N; Ueno Y; Takaishi H; Watanabe M; Ishii H
    J Gastroenterol; 1995 Nov; 30 Suppl 8():121-3. PubMed ID: 8563872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Azathioprine, 6-mercaptopurine and thiopurine S-methyltransferase.
    Roberts-Thomson IC; Butler WJ
    J Gastroenterol Hepatol; 2005 Jun; 20(6):955. PubMed ID: 15946151
    [No Abstract]   [Full Text] [Related]  

  • 9. Management of steroid-dependent ulcerative colitis: immunomodulatory agents, biologics, or surgery?
    Velayos F; Mahadevan U
    Clin Gastroenterol Hepatol; 2007 Jun; 5(6):668-71. PubMed ID: 17544992
    [No Abstract]   [Full Text] [Related]  

  • 10. [The treatment of ulcerative colitis in childhood].
    Schäfer KH; Bläker F
    Monatsschr Kinderheilkd (1902); 1970 Aug; 118(8):511-5. PubMed ID: 5511842
    [No Abstract]   [Full Text] [Related]  

  • 11. Tolerability and safety of mercaptopurine in azathioprine-intolerant patients with inflammatory bowel disease.
    Lees CW; Maan AK; Hansoti B; Satsangi J; Arnott ID
    Aliment Pharmacol Ther; 2008 Feb; 27(3):220-7. PubMed ID: 17988235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous cyclosporin in ulcerative colitis: a five-year experience.
    Cohen RD; Stein R; Hanauer SB
    Am J Gastroenterol; 1999 Jun; 94(6):1587-92. PubMed ID: 10364029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medical management of ulcerative proctitis, proctosigmoiditis, and left-sided colitis.
    Bitton A
    Semin Gastrointest Dis; 2001 Oct; 12(4):263-74. PubMed ID: 11726080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of immunosuppressives.
    Korelitz BI
    Mt Sinai J Med; 1983; 50(2):144-7. PubMed ID: 6343848
    [No Abstract]   [Full Text] [Related]  

  • 15. 6-mercaptopurine-induced hepatotoxicity during the treatment of ulcerative colitis: a case study.
    Chen J; Brady P; Saloum Y; Lara S
    Gastroenterol Nurs; 2015; 38(1):65-8. PubMed ID: 25636015
    [No Abstract]   [Full Text] [Related]  

  • 16. Efficacy and safety of azathioprine and 6-mercaptopurine in Japanese pediatric patients with ulcerative colitis: a survey of the Japanese Society for Pediatric Inflammatory Bowel Disease.
    Tajiri H; Tomomasa T; Yoden A; Konno M; Sasaki M; Maisawa S; Sumazaki R; Shimizu T; Toyoda S; Etani Y; Nakacho M; Ushijima K; Kobayashi A;
    Digestion; 2008; 77(3-4):150-4. PubMed ID: 18577852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammatory bowel disease potpourri: a vignette-based discussion.
    Lam MY; Feller ER; Lonks JR; Shah SA
    Med Health R I; 2009 Apr; 92(4):121-4. PubMed ID: 19452754
    [No Abstract]   [Full Text] [Related]  

  • 18. Predictive factors associated with immunosuppressive agent use in ulcerative colitis: a case-control study.
    Lau A; Chande N; Ponich T; Gregor JC
    Aliment Pharmacol Ther; 2008 Sep; 28(5):606-13. PubMed ID: 18564323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [New information on the occurrence, etiology, pathogenesis and treatment of ulcerative colitis in childhood. (1st experience with immunosuppressive treatment)].
    Bläker F; Schäfer KH; Wallis H
    Monatsschr Kinderheilkd (1902); 1969 Feb; 117(2):52-6. PubMed ID: 5399050
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunosuppressive therapy of inflammatory bowel disease: a historical perspective.
    Korelitz BI
    Gastroenterologist; 1995 Jun; 3(2):141-52. PubMed ID: 7640945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.